Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Rik Scheper

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Anatomy

Chemicals & Drugs

Living Beings

Mice

Procedures

Disorders

Neoplasms

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
van de Ven Rieneke; Lindenberg Jelle J; Oosterhoff Dinja; van den Tol M Petrousjka; Rosalia Rodney A; Murakami Miho; Everts Maaike; Scheffer George L; Scheper Rik J; de Gruijl Tanja D; Curiel David T
Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3.
van de Ven Rieneke; Oerlemans Ruud; van der Heijden Joost W; Scheffer George L; de Gruijl Tanja D; Jansen Gerrit; Scheper Rik J
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.
van de Ven Rieneke; Scheffer George L; Scheper Rik J; de Gruijl Tanja D
The ABC of dendritic cell development and function.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Rik Scheper (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: van de Ven Rieneke; Lindenberg Jelle J; Oosterhoff Dinja; van den Tol M Petrousjka; Rosalia Rodney A; Murakami Miho; Everts Maaike; Scheffer George L; Scheper Rik J; de Gruijl Tanja D; Curiel David T
Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(9):895-906.
2009: van de Ven Rieneke; Oerlemans Ruud; van der Heijden Joost W; Scheffer George L; de Gruijl Tanja D; Jansen Gerrit; Scheper Rik J
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.
Journal of leukocyte biology 2009;86(5):1075-87.
2009: van de Ven Rieneke; Scheffer George L; Scheper Rik J; de Gruijl Tanja D
The ABC of dendritic cell development and function.
Trends in immunology 2009;30(9):421-9.
2009: van de Ven Rieneke; de Groot Jan; Reurs Anneke W; Wijnands Pepijn G J T B; van de Wetering Koen; Schuetz John D; de Gruijl Tanja D; Scheper Rik J; Scheffer George L
Unimpaired immune functions in the absence of Mrp4 (Abcc4).
Immunology letters 2009;124(2):81-7.
2009: Jacobs John J L; Characiejus Dainius; Scheper Rik J; Stewart Rachel J E; Tan Jurgen F V; Tomova Radosveta; Krastev Zachary; Den Otter Willem
The Amiens Strategy: small phase III trials for clinically relevant progress in the war against cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3062-3; author reply 3063-4.
2009: Kroeze Kim L; Jurgens Wouter J; Doulabi Behrouz Z; van Milligen Florine J; Scheper Rik J; Gibbs Susan
Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES.
The Journal of investigative dermatology 2009;129(6):1569-81.
2009: dos Santos G Galvão; Reinders J; Ouwehand K; Rustemeyer T; Scheper R J; Gibbs S
Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound.
Toxicology and applied pharmacology 2009;236(3):372-82.
2009: van der Heijden Joost W; Oerlemans Ruud; Tak Paul P; Assaraf Yehuda G; Kraan Maarten C; Scheffer George L; van der Laken Conny J; Lems Willem F; Scheper Rik J; Dijkmans Ben A C; Jansen Gerrit
Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
Arthritis and rheumatism 2009;60(3):669-77.
2009: Spiekstra S W; Dos Santos G G; Scheper R J; Gibbs S
Potential method to determine irritant potency in vitro - Comparison of two reconstructed epidermal culture models with different barrier competency.
Toxicology in vitro : an international journal published in association with BIBRA 2009;23(2):349-55.
2009: van der Heijden J W; Oerlemans R; Lems W F; Scheper R J; Dijkmans B A C; Jansen G
The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients.
Clinical and experimental rheumatology 2009;27(1):92-8.
2009: Toebak Mascha J; Gibbs Susan; Bruynzeel Derk P; Scheper Rik J; Rustemeyer Thomas
Dendritic cells: biology of the skin.
Contact dermatitis 2009;60(1):2-20.
2009: Woltman Andrea M; Ter Borg Martijn J; Binda Rekha S; Sprengers Dave; von Blomberg B Mary E; Scheper Rik J; Hayashi Kunihiko; Nishi Nobusuke; Boonstra André; van der Molen Renate; Janssen Harry L A
Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial.
Antiviral therapy 2009;14(6):809-18.
2009: van der Lelij Petra; Godthelp Barbara C; van Zon Wouter; van Gosliga Djoke; Oostra Anneke B; Steltenpool Jûrgen; de Groot Jan; Scheper Rik J; Wolthuis Rob M; Waisfisz Quinten; Darroudi Firouz; Joenje Hans; de Winter Johan P
The cellular phenotype of Roberts syndrome fibroblasts as revealed by ectopic expression of ESCO2.
PloS one 2009;4(9):e6936.
2008: Moreno María; Mol Berber M; von Mensdorff-Pouilly Silvia; Verheijen René H M; von Blomberg B Mary E; van den Eertwegh Alfons J M; Scheper Rik J; Bontkes Hetty J
Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC).
Cancer letters 2008;272(1):70-6.
2008: Santegoets Saskia J A M; van den Eertwegh Alfons J M; van de Loosdrecht Arjan A; Scheper Rik J; de Gruijl Tanja D
Human dendritic cell line models for DC differentiation and clinical DC vaccination studies.
Journal of leukocyte biology 2008;84(6):1364-73.
2008: Ouwehand Krista; Santegoets Saskia J A M; Bruynzeel Derk P; Scheper Rik J; de Gruijl Tanja D; Gibbs Susan
CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis.
European journal of immunology 2008;38(11):3050-9.
2008: Molling Johan W; Moreno María; van der Vliet Hans J J; van den Eertwegh Alfons J M; Scheper Rik J; von Blomberg B Mary E; Bontkes Hetty J
Invariant natural killer T cells and immunotherapy of cancer.
Clinical immunology (Orlando, Fla.) 2008;129(2):182-94.
2008: Moreno María; Molling Johan W; von Mensdorff-Pouilly Silvia; Verheijen René H M; von Blomberg B Mary E; van den Eertwegh Alfons J M; Scheper Rik J; Bontkes Hetty J
In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
Clinical immunology (Orlando, Fla.) 2008;129(1):145-54.
2008: de Gruijl Tanja D; van den Eertwegh Alfons J M; Pinedo Herbert M; Scheper Rik J
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.
Cancer immunology, immunotherapy : CII 2008;57(10):1569-77.
2008: van Cruijsen Hester; van der Veldt Astrid A M; Vroling Laura; Oosterhoff Dinja; Broxterman Henk J; Scheper Rik J; Giaccone Giuseppe; Haanen John B A G; van den Eertwegh Alfons J M; Boven Epie; Hoekman Klaas; de Gruijl Tanja D
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5884-92.
2008: van de Ven Rieneke; Scheffer George L; Reurs Anneke W; Lindenberg Jelle J; Oerlemans Ruud; Jansen Gerrit; Gillet Jean-Pierre; Glasgow Joel N; Pereboev Alexander; Curiel David T; Scheper Rik J; de Gruijl Tanja D
A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration.
Blood 2008;112(6):2353-9.
2008: Oerlemans Ruud; Franke Niels E; Assaraf Yehuda G; Cloos Jacqueline; van Zantwijk Ina; Berkers Celia R; Scheffer George L; Debipersad Kabir; Vojtekova Katharina; Lemos Clara; van der Heijden Joost W; Ylstra Bauke; Peters Godefridus J; Kaspers Gertjan L; Dijkmans Ben A C; Scheper Rik J; Jansen Gerrit
Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.
Blood 2008;112(6):2489-99.
2008: Moreno María; Molling Johan W; von Mensdorff-Pouilly Silvia; Verheijen René H M; Hooijberg Erik; Kramer Duco; Reurs Anneke W; van den Eertwegh Alfons J M; von Blomberg B Mary E; Scheper Rik J; Bontkes Hetty J
IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(4):2446-54.
2008: Molenkamp Barbara G; Sluijter Berbel J R; van Leeuwen Paul A M; Santegoets Saskia J A M; Meijer Sybren; Wijnands Pepijn G J T B; Haanen John B A G; van den Eertwegh Alfons J M; Scheper Rik J; de Gruijl Tanja D
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4532-42.
2008: Santegoets Saskia J A M; Gibbs Susan; Kroeze Kim; van de Ven Rieneke; Scheper Rik J; Borrebaeck Carl A; de Gruijl Tanja D; Lindstedt Malin
Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions.
Journal of leukocyte biology 2008;84(1):143-51.
2008: Houtenbos Ilse; Santegoets Saskia; Westers Theresia M; Waisfisz Quinten; Kipriyanov Sergey; Denkers Fedor; Scheper Rik J; de Gruijl Tanja D; Ossenkoppele Gert J; van de Loosdrecht Arjan A
The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity.
British journal of haematology 2008;142(2):273-83.
2008: Molling Johan W; Moreno María; de Groot Jan; van der Vliet Hans J J; von Blomberg B Mary E; van den Eertwegh Alfons J M; Scheper Rik J; Bontkes Hetty J
Chronically stimulated mouse invariant NKT cell lines have a preserved capacity to enhance protection against experimental tumor metastases.
Immunology letters 2008;118(1):36-43.
2008: Santegoets Saskia J A M; Bontkes Hetty J; Stam Anita G M; Bhoelan Farien; Ruizendaal Janneke J; van den Eertwegh Alfons J M; Hooijberg Erik; Scheper Rik J; de Gruijl Tanja D
Inducing antitumor T cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(7):4540-9.
2008: Toebak M J; de Rooij J; Moed H; Stoof T J; von Blomberg B M E; Bruynzeel D P; Scheper R J; Gibbs S; Rustemeyer T
Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs.
The British journal of dermatology 2008;158(2):225-33.
2008: Bernardo David; van Hoogstraten Ingrid M W; Verbeek Wieke H M; Peña A Salvador; Mearin M Luisa; Arranz Eduardo; Garrote José Antonio; Scheper Rik J; Schreurs Marco W J; Bontkes Hetty J; Mulder Chris J J; von Blomberg B Mary E
Decreased circulating iNKT cell numbers in refractory coeliac disease.
Clinical immunology (Orlando, Fla.) 2008;126(2):172-9.
2008: Vriens Abraham P; Waaijman Taco; van den Hoogenband Henk M; de Boer Edith M; Scheper Rik J; Gibbs Susan
Comparison of autologous full-thickness gingiva and skin substitutes for wound healing.
Cell transplantation 2008;17(10-11):1199-209.
2008: van der Deen Margaretha; Homan Sandra; Timmer-Bosscha Hetty; Scheper Rik J; Timens Wim; Postma Dirkje S; de Vries Elisabeth G
Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells.
International journal of chronic obstructive pulmonary disease 2008;3(3):469-75.
2007: Moreno María; Bontkes Hetty J; Scheper Rik J; Kenemans Peter; Verheijen René H M; von Mensdorff-Pouilly Silvia
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).
Cancer letters 2007;257(1):47-55.
2007: Molling Johan W; de Gruijl Tanja D; Glim Judith; Moreno Maria; Rozendaal Lawrence; Meijer Chris J L M; van den Eertwegh Alfons J M; Scheper Rik J; von Blomberg Mary E; Bontkes Hetty J
CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
International journal of cancer. Journal international du cancer 2007;121(8):1749-55.
2007: Oerlemans Ruud; Vink Josefien; Dijkmans Ben A C; Assaraf Yehuda G; van Miltenburg Marjolein; van der Heijden Joost; Ifergan Ilan; Lems Willem F; Scheper Rik J; Kaspers Gertjan J L; Cloos Jacqueline; Jansen Gerrit
Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor alpha and glucocorticoid induced apoptosis.
Annals of the rheumatic diseases 2007;66(10):1289-95.
2007: Spiekstra Sander W; Breetveld Melanie; Rustemeyer Thomas; Scheper Rik J; Gibbs Susan
Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2007;15(5):708-17.
2007: Veldt Bart J; van der Vliet Hans J J; von Blomberg B Mary E; van Vlierberghe Hans; Gerken Guido; Nishi Nobusuke; Hayashi Kunihiko; Scheper Rik J; de Knegt Robert J; van den Eertwegh Alfons J M; Janssen Harry L A; van Nieuwkerk Carin M J
Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
Journal of hepatology 2007;47(3):356-65.
2007: Santegoets Saskia J A M; Schreurs Marco W J; Reurs Anneke W; Lindenberg Jelle J; Kueter Esther W M; van den Eertwegh Alfons J M; Hooijberg Erik; Brandwijk Ricardo J; Hufton Simon E; Hoogenboom Hennie R; Scheper Rik J; Somers Veerle A; de Gruijl Tanja D
Identification and characterization of ErbB-3-binding protein-1 as a target for immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):2005-12.
2007: Duc Q le; Breetveld M; Middelkoop E; Scheper R J; Ulrich M M W; Gibbs S
A cytotoxic analysis of antiseptic medication on skin substitutes and autograft.
The British journal of dermatology 2007;157(1):33-40.
2007: Molenkamp Barbara G; van Leeuwen Paul A M; Meijer Sybren; Sluijter Berbel J R; Wijnands Pepijn G J T B; Baars Arnold; van den Eertwegh Alfons J M; Scheper Rik J; de Gruijl Tanja D
Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2961-9.
2007: Molling Johan W; Moreno Maria; van der Vliet Hans J J; von Blomberg B Mary E; van den Eertwegh Alfons J M; Scheper Rik J; Bontkes Hetty J
Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
Journal of immunological methods 2007;322(1-2):70-81.
2007: Molling Johan W; Langius Jacqueline A E; Langendijk Johannes A; Leemans C René; Bontkes Hetty J; van der Vliet Hans J J; von Blomberg B Mary E; Scheper Rik J; van den Eertwegh Alfons J M
Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):862-8.
2007: Spiewak Radoslaw; Moed Heleen; von Blomberg Brigitta Mary E; Bruynzeel Derk P; Scheper Rik J; Gibbs Susan; Rustemeyer Thomas
Allergic contact dermatitis to nickel: modified in vitro test protocols for better detection of allergen-specific response.
Contact dermatitis 2007;56(2):63-9.
2007: van der Heijden Joost W; Dijkmans Ben A C; Scheper Rik J; Jansen Gerrit
Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside.
Nature clinical practice. Rheumatology 2007;3(1):26-34.
2007: van Cruijsen H; Hoekman K; Stam A G M; van den Eertwegh A J M; Kuenen B C; Scheper R J; Giaccone G; de Gruijl T D
Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor.
Clinical & developmental immunology 2007;2007():17315.
2007: van der Deen Margaretha; Timens Wim; Timmer-Bosscha Hetty; van der Strate Barry W; Scheper Rik J; Postma Dirkje S; de Vries Elisabeth G; Kerstjens Huib A
Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice.
Respiratory research 2007;8():49.
2006: van der Deen Margaretha; Marks Hendrik; Willemse Brigitte W M; Postma Dirkje S; Müller Michael; Smit Egbert F; Scheffer George L; Scheper Rik J; de Vries Elisabeth G E; Timens Wim
Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.
Virchows Archiv : an international journal of pathology 2006;449(6):682-8.
2006: Santegoets Saskia J A M; Masterson Allan J; van der Sluis Pieter C; Lougheed Sinéad M; Fluitsma Donna M; van den Eertwegh Alfons J M; Pinedo Herbert M; Scheper Rik J; de Gruijl Tanja D
A CD34(+) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14(+)CD11b(+) Langerhans cell precursor.
Journal of leukocyte biology 2006;80(6):1337-44.
2006: Santegoets Saskia J A M; Schreurs Marco W J; Masterson Allan J; Liu Ying Poi; Goletz Steffen; Baumeister Hans; Kueter Esther W M; Lougheed Sinéad M; van den Eertwegh Alfons J M; Scheper Rik J; Hooijberg Erik; de Gruijl Tanja D
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
Cancer immunology, immunotherapy : CII 2006;55(12):1480-90.
2006: van der Vliet Hans J J; van Vonderen Marit G A; Molling Johan W; Bontkes Hetty J; Reijm Martine; Reiss Peter; van Agtmael Michiel A; Danner Sven A; van den Eertwegh Alfons J M; von Blomberg B Mary E; Scheper Rik J
Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(9):5775-8.
2006: Toebak Mascha J; Moed Heleen; von Blomberg Mary B E; Bruynzeel Derk P; Gibbs Susan; Scheper Rik J; Rustemeyer Thomas
Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells.
Contact dermatitis 2006;55(4):238-45.
2006: Medhurst Annette L; Laghmani El Houari; Steltenpool Jurgen; Ferrer Miriam; Fontaine Chantal; de Groot Jan; Rooimans Martin A; Scheper Rik J; Meetei Amom Ruhikanta; Wang Weidong; Joenje Hans; de Winter Johan P
Evidence for subcomplexes in the Fanconi anemia pathway.
Blood 2006;108(6):2072-80.
2006: de Gruijl Tanja D; Ophorst Olga J A E; Goudsmit Jaap; Verhaagh Sandra; Lougheed Sinéad M; Radosevic Katarina; Havenga Menzo J E; Scheper Rik J
Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2208-15.
2006: Gibbs S; van den Hoogenband H M; Kirtschig G; Richters C D; Spiekstra S W; Breetveld M; Scheper R J; de Boer E M
Autologous full-thickness skin substitute for healing chronic wounds.
The British journal of dermatology 2006;155(2):267-74.
2006: Breetveld Melanie; Richters Cornelia D; Rustemeyer Thomas; Scheper Rik J; Gibbs Susan
Comparison of wound closure after burn and cold injury in human skin equivalents.
The Journal of investigative dermatology 2006;126(8):1918-21.
2006: de Gruijl Tanja D; Sombroek Claudia C; Lougheed Sinéad M; Oosterhoff Dinja; Buter Jan; van den Eertwegh Alfons J M; Scheper Rik J; Pinedo Herbert M
A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7232-42.
2006: Vuylsteke Ronald J C L M; Molenkamp Barbara G; van Leeuwen Paul A M; Meijer Sybren; Wijnands Pepijn G J T B; Haanen John B A G; Scheper Rik J; de Gruijl Tanja D
Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2826-33.
2006: van de Ven Rieneke; de Jong Mariska C; Reurs Anneke W; Schoonderwoerd Antoinet J N; Jansen Gerrit; Hooijberg Jan H; Scheffer George L; de Gruijl Tanja D; Scheper Rik J
Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5191-8.
2006: Haanen J B A G; Baars A; Gomez R; Weder P; Smits M; de Gruijl T D; von Blomberg B M E; Bloemena E; Scheper R J; van Ham S M; Pinedo H M; van den Eertwegh A J M
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
Cancer immunology, immunotherapy : CII 2006;55(4):451-8.
2006: Bontkes Hetty J; Ruizendaal Janneke J; Kramer Duco; Santegoets Saskia J A M; Scheper Rik J; de Gruijl Tanja D; Meijer Chris J L M; Hooijberg Erik
Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(2):188-200.
2006: Oerlemans Ruud; van der Heijden Joost; Vink Josefien; Dijkmans Ben A C; Kaspers Gertjan J L; Lems Willem F; Scheffer George L; Ifergan Ilan; Scheper Rik J; Cloos Jacqueline; Assaraf Yehuda G; Jansen Gerrit
Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids.
Arthritis and rheumatism 2006;54(2):557-68.
2006: Sisodiya S M; Martinian L; Scheffer G L; van der Valk P; Scheper R J; Harding B N; Thom M
Vascular colocalization of P-glycoprotein, multidrug-resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies.
Neuropathology and applied neurobiology 2006;32(1):51-63.
2006: van Zon Arend; Mossink Marieke H; Houtsmuller Adriaan B; Schoester Martijn; Scheffer George L; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
Vault mobility depends in part on microtubules and vaults can be recruited to the nuclear envelope.
Experimental cell research 2006;312(3):245-55.
2006: Toebak M J; Pohlmann P R; Sampat-Sardjoepersad S C; von Blomberg B M E; Bruynzeel D P; Scheper R J; Rustemeyer T; Gibbs S
CXCL8 secretion by dendritic cells predicts contact allergens from irritants.
Toxicology in vitro : an international journal published in association with BIBRA 2006;20(1):117-24.
2006: Molenkamp Barbara G; van Leeuwen Paul A M; van den Eertwegh Alfons J M; Sluijter Berbel J R; Scheper Rik J; Meijer Sybren; de Gruijl Tanja D
Immunomodulation of the melanoma sentinel lymph node: a novel adjuvant therapeutic option.
Immunobiology 2006;211(6-8):651-61.
2005: Raaijmakers Marc H G P; de Grouw Elke P L M; Heuver Leonie H H; van der Reijden Bert A; Jansen Joop H; Scheffer George; Scheper Rik J; de Witte Theo J M; Raymakers Reinier A P
Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma.
Leukemia research 2005;29(12):1455-8.
2005: Molenkamp Barbara G; Vuylsteke Ronald J C L M; van Leeuwen Paul A M; Meijer Sybren; Vos Wim; Wijnands Pepijn G J T B; Scheper Rik J; de Gruijl Tanja D
Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells.
The American journal of pathology 2005;167(5):1301-7.
2005: Moed H; von Blomberg B M E; Bruynzeel D P; Scheper R J; Gibbs S; Rustemeyer T
Regulation of nickel-induced T-cell responsiveness by CD4+CD25+ cells in contact allergic patients and healthy individuals.
Contact dermatitis 2005;53(2):71-4.
2005: Moed Helen; von Blomberg Mary; Bruynzeel Derk P; Scheper Rik; Gibbs Susan; Rustemeyer Thomas
Improved detection of allergen-specific T-cell responses in allergic contact dermatitis through the addition of 'cytokine cocktails'.
Experimental dermatology 2005;14(8):634-40.
2005: Molling Johan W; Kölgen Wendy; van der Vliet Hans J J; Boomsma Martijn F; Kruizenga Hinke; Smorenburg Carolien H; Molenkamp Barbara G; Langendijk Johannes A; Leemans C René; von Blomberg B Mary E; Scheper Rik J; van den Eertwegh Alfons J M
Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load.
International journal of cancer. Journal international du cancer 2005;116(1):87-93.
2005: Hensbergen Paul J; Wijnands Pepijn G J T B; Schreurs Marco W J; Scheper Rik J; Willemze Rein; Tensen Cornelis P
The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(4):343-51.
2005: Gorgels Theo G M F; Hu Xiaofeng; Scheffer George L; van der Wal Allard C; Toonstra Johan; de Jong Paulus T V M; van Kuppevelt Toin H; Levelt Christiaan N; de Wolf Anneke; Loves Willem J P; Scheper Rik J; Peek Ron; Bergen Arthur A B
Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum.
Human molecular genetics 2005;14(13):1763-73.
2005: Aronica Eleonora; Gorter Jan A; Redeker Sandra; van Vliet Erwin A; Ramkema Marja; Scheffer George L; Scheper Rik J; van der Valk Paul; Leenstra Sieger; Baayen Johannes C; Spliet Wim G M; Troost Dirk
Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain.
Epilepsia 2005;46(6):849-57.
2005: Korokhov Nikolay; Noureddini Sam C; Curiel David T; Santegoets Saskia J A M; Scheper Rik J; de Gruijl Tanja D
A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system.
Molecular pharmaceutics 2005;2(3):218-23.
2005: Stein Ulrike; Bergmann Stephan; Scheffer George L; Scheper Rik J; Royer Hans-Dieter; Schlag Peter M; Walther Wolfgang
YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Oncogene 2005;24(22):3606-18.
2005: Nieuwenhuis Edward E S; Gillessen Silke; Scheper Rik J; Exley Mark A; Taniguchi Masaru; Balk Steven P; Strominger Jack L; Dranoff Glenn; Blumberg Richard S; Wilson S Brian
CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity.
Experimental dermatology 2005;14(4):250-8.
2005: Raaijmakers Marc H G P; de Grouw Elke P L M; Heuver Leonie H H; van der Reijden Bert A; Jansen Joop H; Scheper Rik J; Scheffer George L; de Witte Theo J M; Raymakers Reinier A P
Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2436-44.
2005: Korokhov Nikolay; de Gruijl Tanja D; Aldrich Wayne A; Triozzi Pierre L; Banerjee Papia T; Gillies Stephen D; Curiel Tyler J; Douglas Joanne T; Scheper Rik J; Curiel David T
High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN.
Cancer biology & therapy 2005;4(3):289-94.
2005: Spiekstra S W; Toebak M J; Sampat-Sardjoepersad S; van Beek P J; Boorsma D M; Stoof T J; von Blomberg B M E; Scheper R J; Bruynzeel D P; Rustemeyer T; Gibbs S
Induction of cytokine (interleukin-1alpha and tumor necrosis factor-alpha) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure.
Experimental dermatology 2005;14(2):109-16.
2005: van der Vliet Hans J J; Molling Johan W; von Blomberg B Mary E; Kölgen Wendy; Stam Anita G; de Gruijl Tanja D; Mulder Chris J; Janssen Harry L A; Nishi Nobusuke; van den Eertwegh Alfons J M; Scheper Rik J; van Nieuwkerk Carin J M
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
Clinical immunology (Orlando, Fla.) 2005;114(2):183-9.
2005: van der Deen Margaretha; de Vries Elisabeth G E; Timens Wim; Scheper Rik J; Timmer-Bosscha Hetty; Postma Dirkje S
ATP-binding cassette (ABC) transporters in normal and pathological lung.
Respiratory research 2005;6():59.
2004: Moed H; Stoof T J; Boorsma D M; von Blomberg B M E; Gibbs S; Bruynzeel D P; Scheper R J; Rustemeyer T
Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2 T cell profiles.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(12):1868-75.
2004: Vuylsteke Ronald J C L M; Molenkamp Barbara G; Gietema Hester A; van Leeuwen Paul A M; Wijnands Pepijn G J T B; Vos Wim; van Diest Paul J; Scheper Rik J; Meijer Sybren; de Gruijl Tanja D
Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma.
Cancer research 2004;64(22):8456-60.
2004: Rustemeyer T; von Blomberg B M E; van Hoogstraten I M W; Bruynzeel D P; Scheper R J
Analysis of effector and regulatory immune reactivity to nickel.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2004;34(9):1458-66.
2004: Leggas Markos; Adachi Masashi; Scheffer George L; Sun Daxi; Wielinga Peter; Du Guoqing; Mercer Kelly E; Zhuang Yanli; Panetta John C; Johnston Brad; Scheper Rik J; Stewart Clinton F; Schuetz John D
Mrp4 confers resistance to topotecan and protects the brain from chemotherapy.
Molecular and cellular biology 2004;24(17):7612-21.
2004: Moed Heleen; Boorsma Dick M; Tensen Cornelis P; Flier Jacoba; Jonker Maureen J; Stoof Tom J; von Blomberg B Mary E; Bruynzeel Derk P; Scheper Rik J; Rustemeyer Thomas; Gibbs Susan
Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory.
The Journal of pathology 2004;204(1):39-46.
2004: Moed H; Boorsma D M; Stoof T J; von Blomberg B M E; Bruynzeel D P; Scheper R J; Gibbs S; Rustemeyer T
Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.
The British journal of dermatology 2004;151(1):32-41.
2004: van Zon Arend; Mossink Marieke H; Schoester Martijn; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
Cancer research 2004;64(14):4887-92.
2004: Jansen Gerrit; van der Heijden Joost; Oerlemans Ruud; Lems Willem F; Ifergan Ilan; Scheper Rik J; Assaraf Yehuda G; Dijkmans Ben A C
Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Arthritis and rheumatism 2004;50(7):2130-9.
2004: van der Vliet Hans J J; Molling Johan W; von Blomberg B Mary E; Nishi Nobusuke; Kölgen Wendy; van den Eertwegh Alfons J M; Pinedo Herbert M; Giaccone Giuseppe; Scheper Rik J
The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
Clinical immunology (Orlando, Fla.) 2004;112(1):8-23.
2004: Houtenbos I; Westers T M; de Gruijl T D; Scheper R J; Ossenkoppele G J; van de Loosdrecht A A
TNF-alpha receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1149-53.
2004: Aronica Eleonora; Gorter Jan A; Ramkema Marja; Redeker Sandra; Ozbas-Gerçeker Filiz; van Vliet Edwin A; Scheffer George L; Scheper Rik J; van der Valk Paul; Baayen Johannes C; Troost Dirk;
Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy.
Epilepsia 2004;45(5):441-51.
2004: Boelens P G; Fonk J C M; Houdijk A P J; Scheper R J; Haarman H J T H M; Meijer S; Van Leeuwen P A M; von Blomberg-van der Flier B M E
Primary immune response to keyhole limpet haemocyanin following trauma in relation to low plasma glutamine.
Clinical and experimental immunology 2004;136(2):356-64.
2004: van der Heijden J; de Jong M C; Dijkmans B A C; Lems W F; Oerlemans R; Kathmann I; Schalkwijk C G; Scheffer G L; Scheper R J; Jansen G
Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha.
Annals of the rheumatic diseases 2004;63(2):138-43.
2004: van der Heijden J; de Jong M C; Dijkmans B A C; Lems W F; Oerlemans R; Kathmann I; Scheffer G L; Scheper R J; Assaraf Y G; Jansen G
Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs.
Annals of the rheumatic diseases 2004;63(2):131-7.
2003: Sisodiya Sanjay M; Martinian Lillian; Scheffer George L; van der Valk Paul; Cross J Helen; Scheper Rik J; Harding Brian N; Thom Maria
Major vault protein, a marker of drug resistance, is upregulated in refractory epilepsy.
Epilepsia 2003;44(11):1388-96.
2003: Plasschaert Sabine L A; van der Kolk Dorina M; de Bont Eveline S J M; Kamps Willem A; Morisaki Kuniaki; Bates Susan E; Scheffer George L; Scheper Rik J; Vellenga Edo; de Vries Elisabeth G E
The role of breast cancer resistance protein in acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5171-7.
2003: van Zon Arend; Mossink Marieke H; Schoester Martijn; Houtsmuller Adriaan B; Scheffer George L; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
Journal of cell science 2003;116(Pt 21):4391-400.
2003: Rustemeyer T; Preuss M; von Blomberg B M E; Das P K; Scheper R J
Comparison of two in vitro dendritic cell maturation models for screening contact sensitizers using a panel of methacrylates.
Experimental dermatology 2003;12(5):682-91.
2003: de Jong Mariska C; Scheffer George L; Broxterman Henk J; Hooijberg Jan H; Slootstra Jerry W; Meloen Rob H; Kreitman Robert J; Husain Syed R; Joshi Bharat H; Puri Raj K; Scheper Rik J
Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):5009-17.
2003: Mossink Marieke H; van Zon Arend; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
Vaults: a ribonucleoprotein particle involved in drug resistance?
Oncogene 2003;22(47):7458-67.
2003: Stam A G M; Santegoets S J A M; Westers T M; Sombroek C C; Janssen J J W M; Tillman B W; van de Loosdrecht A A; Pinedo H M; Curiel D T; Ossenkoppele G J; Scheper R J; de Gruijl T D
CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation.
British journal of cancer 2003;89(7):1162-5.
2003: Diestra Julio E; Condom Enric; Del Muro Xavier García; Scheffer George L; Pérez Javier; Zurita Amado J; Muñoz-Seguí José; Vigués Francisco; Scheper Rik J; Capellá Gabriel; Germà-Lluch José R; Izquierdo Miguel A
Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
The Journal of urology 2003;170(4 Pt 1):1383-7.
2003: van Zon A; Mossink M H; Scheper R J; Sonneveld P; Wiemer E A C
The vault complex.
Cellular and molecular life sciences : CMLS 2003;60(9):1828-37.
2003: Mossink Marieke H; de Groot Jan; van Zon Arend; Fränzel-Luiten Erna; Schoester Martijn; Scheffer George L; Sonneveld Pieter; Scheper Rik J; Wiemer Erik A C
Unimpaired dendritic cell functions in MVP/LRP knockout mice.
Immunology 2003;110(1):58-65.
2003: Aronica Eleonora; Gorter Jan A; van Vliet Erwin A; Spliet Wim G M; van Veelen Cees W M; van Rijen Peter C; Leenstra Sieger; Ramkema Marja D; Scheffer George L; Scheper Rik J; Sisodiya Sanjay M; Troost Dirk
Overexpression of the human major vault protein in gangliogliomas.
Epilepsia 2003;44(9):1166-75.
2003: van der Vliet Hans J J; Molling Johan W; Nishi Nobusuke; Masterson Allan J; Kölgen Wendy; Porcelli Steven A; van den Eertwegh Alfons J M; von Blomberg B Mary E; Pinedo Herbert M; Giaccone Giuseppe; Scheper Rik J
Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
Cancer research 2003;63(14):4101-6.
2003: Ossenkoppele G J; Stam A G M; Westers T M; de Gruijl T D; Janssen J J W M; van de Loosdrecht A A; Scheper R J
Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(7):1424-6.
2003: Houtenbos Ilse; Westers Theresia M; Stam Anita G M; de Gruijl Tanja D; Scheper Rik J; Ossenkoppele Gert J; van de Loosdrecht Arjan A
Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
Cancer immunology, immunotherapy : CII 2003;52(7):455-62.
2003: Brandão Joana G; Scheper Rik J; Lougheed Sinéad M; Curiel David T; Tillman Bryan W; Gerritsen Winald R; van den Eertwegh Alfons J M; Pinedo Herbert M; Haisma Hidde J; de Gruijl Tanja D
CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation.
Vaccine 2003;21(19-20):2268-72.
2003: Komdeur R; Plaat B E C; van der Graaf W T A; Hoekstra H J; Hollema H; van den Berg E; Zwart N; Scheper R J; Molenaar W M
Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
European journal of cancer (Oxford, England : 1990) 2003;39(7):909-16.
2003: Schäfer Hubert; Scheper Rik J; Borsdorf Bettina; Burger Reinhard;
Effector functions of CD8-positive guinea pig T lymphocytes.
Cellular immunology 2003;222(2):134-43.
2003: Zurita A J; Diestra J E; Condom E; García Del Muro X; Scheffer G L; Scheper R J; Pérez J; Germà-Lluch J R; Izquierdo M A
Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
British journal of cancer 2003;88(6):879-86.
2003: van der Pol Marjolein A; Broxterman Henk J; Pater Jennie M; Feller Nicole; van der Maas Martin; Weijers Geert W D; Scheffer George L; Allen John D; Scheper Rik J; van Loevezijn Arnold; Ossenkoppele Gert J; Schuurhuis Gerrit J
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
Haematologica 2003;88(2):134-47.
2003: Mayer Frank; Stoop Hans; Scheffer George L; Scheper Rik; Oosterhuis J Wolter; Looijenga Leendert H J; Bokemeyer Carsten
Molecular determinants of treatment response in human germ cell tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):767-73.
2003: Westers Theresia M; Stam Anita G M; Scheper Rik J; Regelink Johanna C; Nieuwint Aggie W M; Schuurhuis Gerrit Jan; van de Loosdrecht Arjan A; Ossenkoppele Gert J
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
Cancer immunology, immunotherapy : CII 2003;52(1):17-27.
2003: Aronica E; Gorter J A; Jansen G H; van Veelen C W M; van Rijen P C; Leenstra S; Ramkema M; Scheffer G L; Scheper R J; Troost D
Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: focal cortical dysplasia and glioneuronal tumors.
Neuroscience 2003;118(2):417-29.
2002: Mossink Marieke H; van Zon Arend; Fränzel-Luiten Erna; Schoester Martijn; Kickhoefer Valerie A; Scheffer George L; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Cancer research 2002;62(24):7298-304.
2002: Giaccone Giuseppe; Punt Cornelis J A; Ando Yoshitaka; Ruijter Rita; Nishi Nobusuke; Peters Marlies; von Blomberg B Mary E; Scheper Rik J; van der Vliet Hans J J; van den Eertwegh Alfons J M; Roelvink Marja; Beijnen Jos; Zwierzina Heinz; Pinedo Herbert M
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3702-9.
2002: Jonker Johan W; Buitelaar Marije; Wagenaar Els; Van Der Valk Martin A; Scheffer George L; Scheper Rik J; Plosch Torsten; Kuipers Folkert; Elferink Ronald P J Oude; Rosing Hilde; Beijnen Jos H; Schinkel Alfred H
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(24):15649-54.
2002: de Gruijl Tanja D; Luykx-de Bakker Sylvia A; Tillman Bryan W; van den Eertwegh Alfons J M; Buter Jan; Lougheed Sinéad M; van der Bij Gerben J; Safer A Mahmoud; Haisma Hidde J; Curiel David T; Scheper Rik J; Pinedo Herbert M; Gerritsen Winald R
Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(9):5322-31.
2002: Diestra Julio E; Scheffer George L; Català Isabel; Maliepaard Marc; Schellens Jan H M; Scheper Rik J; Germà-Lluch Jose R; Izquierdo Miguel A
Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material.
The Journal of pathology 2002;198(2):213-9.
2002: van Hattum A H; Hoogsteen I J; Schlüper H M M; Maliepaard M; Scheffer G L; Scheper R J; Kohlhagen G; Pommier Y; Pinedo H M; Boven E
Induction of breast cancer resistance protein by the camptothecin derivative DX-8951f is associated with minor reduction of antitumour activity.
British journal of cancer 2002;87(6):665-72.
2002: van der Vliet Hans J J; Pinedo Herbert M; von Blomberg B Mary E; van den Eertwegh Alfons J M; Scheper Rik J; Giaccone Giuseppe
Natural Killer T cells.
The lancet oncology 2002;3(9):574.
2002: Somers Veerle A; Brandwijk Ricardo J; Joosten Ben; Moerkerk Peter T; Arends Jan-Willem; Menheere Paul; Pieterse Wendy O; Claessen Anke; Scheper Rik J; Hoogenboom Hennie R; Hufton Simon E
A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(5):2772-80.
2002: Bontkes Hetty J; De Gruijl Tanja D; Schuurhuis Gert Jan; Scheper Rik J; Meijer Chris J L M; Hooijberg Erik
Expansion of dendritic cell precursors from human CD34(+) progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome.
Journal of leukocyte biology 2002;72(2):321-9.
2002: Mossink Marieke; van Zon Arend; Fränzel-Luiten Erna; Schoester Martijn; Scheffer George L; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
The genomic sequence of the murine major vault protein and its promoter.
Gene 2002;294(1-2):225-32.
2002: Scheffer George L; Flens Marcel J; Hageman Sandra; Izquierdo Miguel A; Shoemaker Robert H; Scheper Rik J
Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells.
European journal of cancer (Oxford, England : 1990) 2002;38(11):1535-42.
2002: Vuylsteke Ronald J C L M; van Leeuwen Paul A M; Meijer Sybren; Wijnands Pepijn G J T B; Statius Muller Markwin G; Busch Dirk H; Scheper Rik J; de Gruijl Tanja D
Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.
The American journal of pathology 2002;161(1):19-26.
2002: Masterson Allan J; Sombroek Claudia C; De Gruijl Tanja D; Graus Yvo M F; van der Vliet Hans J J; Lougheed Sinéad M; van den Eertwegh Alfons J M; Pinedo Herbert M; Scheper Rik J
MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors.
Blood 2002;100(2):701-3.
2002: Minderman Hans; Suvannasankha Attaya; O'Loughlin Kieran L; Scheffer George L; Scheper Rik J; Robey Robert W; Baer Maria R
Flow cytometric analysis of breast cancer resistance protein expression and function.
Cytometry 2002;48(2):59-65.
2002: Rustemeyer Thomas; de Groot Jan; von Blomberg B Mary E; Bruynzeel Derk P; Frosch Peter J; Scheper Rik J
Assessment of contact allergen cross-reactivity by retesting.
Experimental dermatology 2002;11(3):257-65.
2002: Scheffer G L; de Jong M C; Monks A; Flens M J; Hose C D; Izquierdo M A; Shoemaker R H; Scheper R J
Increased expression of beta 2-microglobulin in multidrug-resistant tumour cells.
British journal of cancer 2002;86(12):1943-50.
2002: Scheffer G L; Pijnenborg A C L M; Smit E F; Müller M; Postma D S; Timens W; van der Valk P; de Vries E G E; Scheper R J
Multidrug resistance related molecules in human and murine lung.
Journal of clinical pathology 2002;55(5):332-9.
2002: van der Kolk Dorina M; Vellenga Edo; Scheffer George L; Müller Michael; Bates Susan E; Scheper Rik J; de Vries Elisabeth G E
Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.
Blood 2002;99(10):3763-70.
2002: Sombroek Claudia C; Stam Anita G M; Masterson Allan J; Lougheed Sinéad M; Schakel Marcel J A G; Meijer Chris J L M; Pinedo Herbert M; van den Eertwegh Alfons J M; Scheper Rik J; de Gruijl Tanja D
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(9):4333-43.
2002: Baars A; Claessen A M E; Wagstaff J; Giaccone G; Scheper R J; Meijer S; Schakel M J A G; Gall H E; Meijer C J L M; Vermorken J B; Pinedo H M; van den Eertwegh A J M
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma.
British journal of cancer 2002;86(8):1230-4.
2002: Scheffer George L; Hu Xiaofeng; Pijnenborg Adriana C L M; Wijnholds Jan; Bergen Arthur A B; Scheper Rik J
MRP6 (ABCC6) detection in normal human tissues and tumors.
Laboratory investigation; a journal of technical methods and pathology 2002;82(4):515-8.
2002: Faneyte Ian F; Kristel Petra M P; Maliepaard Marc; Scheffer George L; Scheper Rik J; Schellens Jan H M; van de Vijver Marc J
Expression of the breast cancer resistance protein in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(4):1068-74.
2002: Scheffer G L; Reurs A W; Jutten B; Beiboer S H W; van Amerongen R; Schoester M; Wiemer E A C; Hoogenboom H R; Scheper R J
Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein.
British journal of cancer 2002;86(6):954-62.
2002: van Zon Arend; Mossink Marieke H; Schoester Martijn; Scheffer George L; Scheper Rik J; Sonneveld Pieter; Wiemer Erik A C
Structural domains of vault proteins: a role for the coiled coil domain in vault assembly.
Biochemical and biophysical research communications 2002;291(3):535-41.
2002: Scheffer George L; Kool Marcel; de Haas Marcel; de Vree J Marleen L; Pijnenborg Adriana C L M; Bosman Diederik K; Elferink Ronald P J Oude; van der Valk Paul; Borst Piet; Scheper Rik J
Tissue distribution and induction of human multidrug resistant protein 3.
Laboratory investigation; a journal of technical methods and pathology 2002;82(2):193-201.
2002: Schroeijers Anouk B; Reurs Anneke W; Scheffer George L; Stam Anita G M; de Jong Mariska C; Rustemeyer Thomas; Wiemer Erik A C; de Gruijl Tanja D; Scheper Rik J
Up-regulation of drug resistance-related vaults during dendritic cell development.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1572-8.
2002: van der Vliet Hans J J; von Blomberg B Mary E; Hazenberg Mette D; Nishi Nobusuke; Otto Sigrid A; van Benthem Birgit H; Prins Maria; Claessen Frans A; van den Eertwegh Alfons J M; Giaccone Giuseppe; Miedema Frank; Scheper Rik J; Pinedo Herbert M
Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1490-5.
2002: Coley Helen M; Sargent Jean M; Williamson Christine J; Titley Jenny; Scheper Rik J; Gregson Sarah E; Elgie Alena W; Lewandowicz Grazyna M; Taylor Colin G
Assessment of the classical MDR phenotype in epithelial ovarian carcinoma using primary cultures: a feasibility study.
Anticancer research 2002;22(1A):69-74.
2002: Brinkhuis Mariël; Izquierdo Miguel A; Baak Jan P A; van Diest Paul J; Kenemans Peter; Scheffer George L; Scheper Rik J
Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancer.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2002;24(1):17-23.
2002: Scheffer George L; Scheper Rik J
Drug resistance molecules: lessons from oncology.
Novartis Foundation symposium 2002;243():19-31; discussion 31-7, 180-5.
2001: Rustemeyer T; de Groot J; von Blomberg B M; Frosch P J; Scheper R J
Induction of tolerance and cross-tolerance to methacrylate contact sensitizers.
Toxicology and applied pharmacology 2001;176(3):195-202.
2001: Sargent J M; Williamson C J; Maliepaard M; Elgie A W; Scheper R J; Taylor C G
Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia.
British journal of haematology 2001;115(2):257-62.
2001: Schroeijers A B; Scheffer G L; Reurs A W; Pijnenborg A C; Abbondanza C; Wiemer E A; Scheper R J
Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2001;49(11):1379-85.
2001: van Zon A; Mossink M H; Schoester M; Scheffer G L; Scheper R J; Sonneveld P; Wiemer E A
Multiple human vault RNAs. Expression and association with the vault complex.
The Journal of biological chemistry 2001;276(40):37715-21.
2001: Hensbergen P J; van der Raaij-Helmer E M; Dijkman R; van der Schors R C; Werner-Felmayer G; Boorsma D M; Scheper R J; Willemze R; Tensen C P
Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity.
European journal of biochemistry / FEBS 2001;268(18):4992-9.
2001: van der Vliet H J; von Blomberg B M; Nishi N; Reijm M; Voskuyl A E; van Bodegraven A A; Polman C H; Rustemeyer T; Lips P; van den Eertwegh A J; Giaccone G; Scheper R J; Pinedo H M
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage.
Clinical immunology (Orlando, Fla.) 2001;100(2):144-8.
2001: Maliepaard M; Scheffer G L; Faneyte I F; van Gastelen M A; Pijnenborg A C; Schinkel A H; van De Vijver M J; Scheper R J; Schellens J H
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Cancer research 2001;61(8):3458-64.
2001: Mels A K; Statius Muller M G; van Leeuwen P A; von Blomberg B M; Scheper R J; Cuesta M A; Beelen R H; Meijer S
Immune-stimulating effects of low-dose perioperative recombinant granulocyte-macrophage colony-stimulating factor in patients operated on for primary colorectal carcinoma.
The British journal of surgery 2001;88(4):539-44.
2001: Siva A C; Raval-Fernandes S; Stephen A G; LaFemina M J; Scheper R J; Kickhoefer V A; Rome L H
Up-regulation of vaults may be necessary but not sufficient for multidrug resistance.
International journal of cancer. Journal international du cancer 2001;92(2):195-202.
2001: de Jong M C; Slootstra J W; Scheffer G L; Schroeijers A B; Puijk W C; Dinkelberg R; Kool M; Broxterman H J; Meloen R H; Scheper R J
Peptide transport by the multidrug resistance protein MRP1.
Cancer research 2001;61(6):2552-7.
2001: van der Vliet HJ; Nishi N; Koezuka Y; von Blomberg BM; van den Eertwegh AJ; Porcelli S A; Pinedo H M; Scheper R J; Giaccone G
Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
Journal of immunological methods 2001;247(1-2):61-72.
2000: Xie Y; de Winter J P; Waisfisz Q; Nieuwint A W; Scheper R J; Arwert F; Hoatlin M E; Ossenkoppele G J; Schuurhuis G J; Joenje H
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
British journal of haematology 2000;111(4):1057-64.
2000: Scheffer G L; Schroeijers A B; Izquierdo M A; Wiemer E A; Scheper R J
Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer.
Current opinion in oncology 2000;12(6):550-6.
2000: de Winter J P; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper R J; Kruyt F A; Hoatlin M E; Joenje H
The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
Human molecular genetics 2000;9(18):2665-74.
2000: Bontkes H J; de Gruijl T D; van den Muysenberg A J; Verheijen R H; Stukart M J; Meijer C J; Scheper R J; Stacey S N; Duggan-Keen M F; Stern P L; Man S; Borysiewicz L K; Walboomers J M
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
International journal of cancer. Journal international du cancer 2000;88(1):92-8.
2000: Scheffer G L; Kool M; Heijn M; de Haas M; Pijnenborg A C; Wijnholds J; van Helvoort A; de Jong M C; Hooijberg J H; Mol C A; van der Linden M; de Vree J M; van der Valk P; Elferink R P; Borst P; Scheper R J
Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.
Cancer research 2000;60(18):5269-77.
2000: Plaat B E; Hollema H; Molenaar W M; Torn Broers G H; Pijpe J; Mastik M F; Hoekstra H J; van den Berg E; Scheper R J; van der Graaf W T
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(18):3211-20.
2000: Baars A; Claessen A M; van den Eertwegh A J; Gall H E; Stam A G; Meijer S; Giaccone G; Meijer C J; Scheper R J; Wagstaff J; Vermorken J B; Pinedo H M
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):965-70.
2000: Dukers D F; Meij P; Vervoort M B; Vos W; Scheper R J; Meijer C J; Bloemena E; Middeldorp J M
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(2):663-70.
2000: Wijnholds J; Mol C A; van Deemter L; de Haas M; Scheffer G L; Baas F; Beijnen J H; Scheper R J; Hatse S; De Clercq E; Balzarini J; Borst P
Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7476-81.
2000: Scheffer G L; Maliepaard M; Pijnenborg A C; van Gastelen M A; de Jong M C; Schroeijers A B; van der Kolk D M; Allen J D; Ross D D; van der Valk P; Dalton W S; Schellens J H; Scheper R J
Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.
Cancer research 2000;60(10):2589-93.
2000: van de Vrugt H J; Cheng N C; de Vries Y; Rooimans M A; de Groot J; Scheper R J; Zhi Y; Hoatlin M E; Joenje H; Arwert F
Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary.
Mammalian genome : official journal of the International Mammalian Genome Society 2000;11(4):326-31.
2000: van Der Vliet H J; Nishi N; de Gruijl T D; von Blomberg B M; van den Eertwegh A J; Pinedo H M; Giaccone G; Scheper R J
Human natural killer T cells acquire a memory-activated phenotype before birth.
Blood 2000;95(7):2440-2.
2000: Nishi N; van der Vliet H J; Koezuka Y; von Blomberg B M; Scheper R J; Pinedo H M; Giaccone G
Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human V alpha 24+V beta 11+ T cells in vitro.
Human immunology 2000;61(4):357-65.
2000: Schroeijers A B; Siva A C; Scheffer G L; de Jong M C; Bolick S C; Dukers D F; Slootstra J W; Meloen R H; Wiemer E; Kickhoefer V A; Rome L H; Scheper R J
The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
Cancer research 2000;60(4):1104-10.
2000: Wijnholds J; deLange E C; Scheffer G L; van den Berg D J; Mol C A; van der Valk M; Schinkel A H; Scheper R J; Breimer D D; Borst P
Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.
The Journal of clinical investigation 2000;105(3):279-85.
2000: de Winter J P; Rooimans M A; van Der Weel L; van Berkel C G; Alon N; Bosnoyan-Collins L; de Groot J; Zhi Y; Waisfisz Q; Pronk J C; Arwert F; Mathew C G; Scheper R J; Hoatlin M E; Buchwald M; Joenje H
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM.
Nature genetics 2000;24(1):15-6.
2000: Schellens J H; Maliepaard M; Scheper R J; Scheffer G L; Jonker J W; Smit J W; Beijnen J H; Schinkel A H
Transport of topoisomerase I inhibitors by the breast cancer resistance protein. Potential clinical implications.
Annals of the New York Academy of Sciences 2000;922():188-94.
1999: Van Der Vliet H J; Nishi N; Koezuka Y; Peyrat M A; Von Blomberg B M; Van Den Eertwegh A J; Pinedo H M; Giaccone G; Scheper R J
Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.
Immunology 1999;98(4):557-63.
1999: Arts H J; Katsaros D; de Vries E G; Massobrio M; Genta F; Danese S; Arisio R; Scheper R J; Kool M; Scheffer G L; Willemse P H; van der Zee A G; Suurmeijer A J
Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2798-805.
1999: Flier J; Boorsma D M; Bruynzeel D P; Van Beek P J; Stoof T J; Scheper R J; Willemze R; Tensen C P
The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions.
The Journal of investigative dermatology 1999;113(4):574-8.
1999: Bontkes H J; de Gruijl T D; Bijl A; Verheijen R H; Meijer C J; Scheper R J; Stern P L; Burns J E; Maitland N J; Walboomers J M
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia.
The Journal of general virology 1999;80 ( Pt 9)():2453-9.
1999: Hooijberg J H; Broxterman H J; Scheffer G L; Vrasdonk C; Heijn M; de Jong M C; Scheper R J; Lankelma J; Pinedo H M
Potent interaction of flavopiridol with MRP1.
British journal of cancer 1999;81(2):269-76.
1999: Waisfisz Q; de Winter J P; Kruyt F A; de Groot J; van der Weel L; Dijkmans L M; Zhi Y; Arwert F; Scheper R J; Youssoufian H; Hoatlin M E; Joenje H
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(18):10320-5.
1999: Rustemeyer T; De Ligter S; Von Blomberg B M; Frosch P J; Scheper R J
Human T lymphocyte priming in vitro by haptenated autologous dendritic cells.
Clinical and experimental immunology 1999;117(2):209-16.
1999: Tensen C P; Flier J; Rampersad S S; Sampat-Sardjoepersad S; Scheper R J; Boorsma D M; Willemze R
Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene.
Biochimica et biophysica acta 1999;1446(1-2):167-72.
1999: Meijer G A; Schroeijers A B; Flens M J; Meuwissen S G; van der Valk P; Baak J P; Scheper R J
Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.
Journal of clinical pathology 1999;52(6):450-4.
1999: Hooijberg J H; Broxterman H J; Kool M; Assaraf Y G; Peters G J; Noordhuis P; Scheper R J; Borst P; Pinedo H M; Jansen G
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Cancer research 1999;59(11):2532-5.
1999: Kool M; van der Linden M; de Haas M; Scheffer G L; de Vree J M; Smith A J; Jansen G; Peters G J; Ponne N; Scheper R J; Elferink R P; Baas F; Borst P
MRP3, an organic anion transporter able to transport anti-cancer drugs.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(12):6914-9.
1999: Tillman B W; de Gruijl T D; Luykx-de Bakker S A; Scheper R J; Pinedo H M; Curiel T J; Gerritsen W R; Curiel D T
Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6378-83.
1999: Tensen C P; Flier J; Van Der Raaij-Helmer E M; Sampat-Sardjoepersad S; Van Der Schors R C; Leurs R; Scheper R J; Boorsma D M; Willemze R
Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3).
The Journal of investigative dermatology 1999;112(5):716-22.
1999: de Gruijl T D; Bontkes H J; van den Muysenberg A J; van Oostveen J W; Stukart M J; Verheijen R H; van der Vange N; Snijders P J; Meijer C J; Walboomers J M; Scheper R J
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix.
European journal of cancer (Oxford, England : 1990) 1999;35(3):490-7.
1999: de Gruijl T D; Bontkes H J; Peccatori F; Gallee M P; Helmerhorst T J; Verheijen R H; Aarbiou J; Mulder W M; Walboomers J M; Meijer C J; van de Vange N; Scheper R J
Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes.
British journal of cancer 1999;79(7-8):1127-32.
1999: Bontkes H J; de Gruijl T D; Walboomers J M; Schiller J T; Dillner J; Helmerhorst T J; Verheijen R H; Scheper R J; Meijer C J
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
The Journal of general virology 1999;80 ( Pt 2)():409-17.
1999: de Gruijl T D; Bontkes H J; Walboomers J M; Coursaget P; Stukart M J; Dupuy C; Kueter E; Verheijen R H; Helmerhorst T J; Duggan-Keen M F; Stern P L; Meijer C J; Scheper R J
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
The Journal of general virology 1999;80 ( Pt 2)():399-408.
1999: Luykx-de Bakker S A; de Gruijl T D; Scheper R J; Wagstaff J; Pinedo H M
Dendritic cells: a novel therapeutic modality.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):21-7.
1999: Vermorken J B; Claessen A M; van Tinteren H; Gall H E; Ezinga R; Meijer S; Scheper R J; Meijer C J; Bloemena E; Ransom J H; Hanna M G; Pinedo H M
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.
Lancet 1999;353(9150):345-50.
1999: van Haselen C W; Flens M J; Scheper R J; van der Valk P; Scheffer G L; Toonstra J; van Vloten W A
Multidrug resistance related proteins in primary cutaneous lymphomas.
Advances in experimental medicine and biology 1999;457():119-31.
1998: Bontkes H J; van Duin M; de Gruijl T D; Duggan-Keen M F; Walboomers J M; Stukart M J; Verheijen R H; Helmerhorst T J; Meijer C J; Scheper R J; Stevens F R; Dyer P A; Sinnott P; Stern P L
HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants.
International journal of cancer. Journal international du cancer 1998;78(2):166-71.
1998: Tensen C P; Vermeer M H; van der Stoop P M; van Beek P; Scheper R J; Boorsma D M; Willemze R
Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.
The Journal of investigative dermatology 1998;111(2):222-6.
1998: de Gruijl T D; Bontkes H J; Walboomers J M; Stukart M J; Doekhie F S; Remmink A J; Helmerhorst T J; Verheijen R H; Duggan-Keen M F; Stern P L; Meijer C J; Scheper R J
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study.
Cancer research 1998;58(8):1700-6.
1998: Van Luyn M J; Müller M; Renes J; Meijer C; Scheper R J; Nienhuis E F; Mulder N H; Jansen P L; De Vries E G
Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1.
International journal of cancer. Journal international du cancer 1998;76(1):55-62.
1998: den Boer M L; Pieters R; Kazemier K M; Rottier M M; Zwaan C M; Kaspers G J; Janka-Schaub G; Henze G; Creutzig U; Scheper R J; Veerman A J
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
Blood 1998;91(6):2092-8.
1998: Schroeijers A B; Scheffer G L; Flens M J; Meijer G A; Izquierdo M A; van der Valk P; Scheper R J
Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.
The American journal of pathology 1998;152(2):373-8.
1998: Rustemeyer T; de Groot J; von Blomberg B M; Frosch P J; Scheper R J
Cross-reactivity patterns of contact-sensitizing methacrylates.
Toxicology and applied pharmacology 1998;148(1):83-90.
1997: Mulder W M; Stern P L; Stukart M J; de Windt E; Butzelaar R M; Meijer S; Adér H J; Claessen A M; Vermorken J B; Meijer C J; Wagstaff J; Scheper R J; Bloemena E
Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(11):1923-30.
1997: van der Pol J P; Blom D J; Flens M J; Luyten G P; de Waard-Siebinga I; Koornneef L; Scheper R J; Jager M J
Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines.
Investigative ophthalmology & visual science 1997;38(12):2523-30.
1997: Flens M J; Scheffer G L; van der Valk P; Broxterman H J; Eijdems E W; Huysmans A C; Izquierdo M A; Scheper R J
Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies.
International journal of cancer. Journal international du cancer 1997;73(2):249-57.
1997: Kool M; de Haas M; Scheffer G L; Scheper R J; van Eijk M J; Juijn J A; Baas F; Borst P
Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Cancer research 1997;57(16):3537-47.
1997: Den Boer M L; Zwaan C M; Pieters R; Kazemier K M; Rottier M M; Flens M J; Scheper R J; Veerman A J
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(7):1078-85.
1997: Paulusma C C; Kool M; Bosma P J; Scheffer G L; ter Borg F; Scheper R J; Tytgat G N; Borst P; Baas F; Oude Elferink R P
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome.
Hepatology (Baltimore, Md.) 1997;25(6):1539-42.
1997: Stein U; Walther W; Laurencot C M; Scheffer G L; Scheper R J; Shoemaker R H
Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Journal of the National Cancer Institute 1997;89(11):807-13.
1997: de Gruijl T D; Bontkes H J; Walboomers J M; Schiller J T; Stukart M J; Groot B S; Chabaud M M; Remmink A J; Verheijen R H; Helmerhorst T J; Meijer C J; Scheper R J
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
Journal of the National Cancer Institute 1997;89(9):630-8.
1997: Mulder W M; Bloemena E; Stukart M J; Kummer J A; Wagstaff J; Scheper R J
T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma.
Gut 1997;40(1):113-9.
1997: Bontkes H J; de Gruijl T D; Walboomers J M; van den Muysenberg A J; Gunther A W; Scheper R J; Meijer C J; Kummer J A
Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.
British journal of cancer 1997;76(10):1353-60.
1997: Nooter K; Brutel de la Riviere G; Look M P; van Wingerden K E; Henzen-Logmans S C; Scheper R J; Flens M J; Klijn J G; Stoter G; Foekens J A
The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.
British journal of cancer 1997;76(4):486-93.
1996: Izquierdo M A; Neefjes J J; Mathari A E; Flens M J; Scheffer G L; Scheper R J
Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
British journal of cancer 1996;74(12):1961-7.
1996: de Gruijl T D; Bontkes H J; Walboomers J M; Stukart M J; Robbesom A A; von Blomberg-van der Flier B M; Herbrink P; Remmink A J; Verheijen R H; Helmerhorst T J; Meijer C J; Scheper R J
Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.
International journal of cancer. Journal international du cancer 1996;68(6):731-8.
1996: Scheper R J; von Blomberg M E; de Groot J; Wolvers D A; Kraal G; Claessen A M
Reversal of orally induced T-cell tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization.
Annals of the New York Academy of Sciences 1996;795():403-9.
1996: de Gruijl T D; Bontkes H J; Stukart M J; Walboomers J M; Remmink A J; Verheijen R H; Helmerhorst T J; Meijer C J; Scheper R J
T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
The Journal of general virology 1996;77 ( Pt 9)():2183-91.
1996: Dingemans A M; van Ark-Otte J; van der Valk P; Apolinario R M; Scheper R J; Postmus P E; Giaccone G
Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(6):625-30.
1996: Mulder W M; Stukart M J; de Windt E; Wagstaff J; Scheper R J; Bloemena E
Mucin-1-related T cell infiltration in colorectal carcinoma.
Cancer immunology, immunotherapy : CII 1996;42(6):351-6.
1996: Claessen A M; von Blomberg B M; De Groot J; Wolvers D A; Kraal G; Scheper R J
Reversal of mucosal tolerance by subcutaneous administration of interleukin-12 at the site of attempted sensitization.
Immunology 1996;88(3):363-7.
1996: Izquierdo M A; Scheffer G L; Flens M J; Schroeijers A B; van der Valk P; Scheper R J
Major vault protein LRP-related multidrug resistance.
European journal of cancer (Oxford, England : 1990) 1996;32A(6):979-84.
1996: Giaccone G; van Ark-Otte J; Rubio G J; Gazdar A F; Broxterman H J; Dingemans A M; Flens M J; Scheper R J; Pinedo H M
MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
International journal of cancer. Journal international du cancer 1996;66(6):760-7.
1996: Flens M J; Zaman G J; van der Valk P; Izquierdo M A; Schroeijers A B; Scheffer G L; van der Groep P; de Haas M; Meijer C J; Scheper R J
Tissue distribution of the multidrug resistance protein.
The American journal of pathology 1996;148(4):1237-47.
1996: Izquierdo M A; Scheffer G L; Flens M J; Giaccone G; Broxterman H J; Meijer C J; van der Valk P; Scheper R J
Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors.
The American journal of pathology 1996;148(3):877-87.
1996: Paulusma C C; Bosma P J; Zaman G J; Bakker C T; Otter M; Scheffer G L; Scheper R J; Borst P; Oude Elferink R P
Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.
Science (New York, N.Y.) 1996;271(5252):1126-8.
1996: Nooter K; Bosman F T; Burger H; van Wingerden K E; Flens M J; Scheper R J; Oostrum R G; Boersma A W; van der Gaast A; Stoter G
Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):75-81.
1996: Izquierdo M A; Shoemaker R H; Flens M J; Scheffer G L; Wu L; Prather T R; Scheper R J
Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines.
International journal of cancer. Journal international du cancer 1996;65(2):230-7.
1996: Izquierdo M A; Scheffer G L; Flens M J; Shoemaker R H; Rome L H; Scheper R J
Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs.
Cytotechnology 1996;19(3):191-7.
1996: Scheper R J; Scheffer G L; Flens M J; van der Valk P; Broxterman H J; Izquierdo M A
Transporter molecules in multidrug resistance.
Cytotechnology 1996;19(3):187-90.
1995: Nooter K; Westerman A M; Flens M J; Zaman G J; Scheper R J; van Wingerden K E; Burger H; Oostrum R; Boersma T; Sonneveld P
Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(11):1301-10.
1995: van Wilsem E J; Breve J; Savelkoul H; Claessen A; Scheper R J; Kraal G
Oral tolerance is determined at the level of draining lymph nodes.
Immunobiology 1995;194(4-5):403-14.
1995: Izquierdo M A; Van der Valk P; Van Ark-Otte J; Rubio G; Germa-Lluch J R; Ueda R; Scheper R J; Takahashi T; Giaccone G
Differential expression of the c-kit proto-oncogene in germ cell tumours.
The Journal of pathology 1995;177(3):253-8.
1995: Mulder W M; Stukart M J; Roos M; van Lier R A; Wagstaff J; Scheper R J; Bloemena E
Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: removal of tumour cells does not affect tumour-specificity.
Cancer immunology, immunotherapy : CII 1995;41(5):293-301.
1995: Feller N; Kuiper C M; Lankelma J; Ruhdal J K; Scheper R J; Pinedo H M; Broxterman H J
Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.
British journal of cancer 1995;72(3):543-9.
1995: Eijdems E W; Zaman G J; de Haas M; Versantvoort C H; Flens M J; Scheper R J; Kamst E; Borst P; Baas F
Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
British journal of cancer 1995;72(2):298-306.
1995: Versantvoort C H; Broxterman H J; Bagrij T; Scheper R J; Twentyman P R
Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
British journal of cancer 1995;72(1):82-9.
1995: Scheffer G L; Wijngaard P L; Flens M J; Izquierdo M A; Slovak M L; Pinedo H M; Meijer C J; Clevers H C; Scheper R J
The drug resistance-related protein LRP is the human major vault protein.
Nature medicine 1995;1(6):578-82.
1995: Versantvoort C H; Withoff S; Broxterman H J; Kuiper C M; Scheper R J; Mulder N H; de Vries E G
Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance.
International journal of cancer. Journal international du cancer 1995;61(3):375-80.
1994: Müller M; Meijer C; Zaman G J; Borst P; Scheper R J; Mulder N H; de Vries E G; Jansen P L
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):13033-7.
1994: Zaman G J; Flens M J; van Leusden M R; de Haas M; Mülder H S; Lankelma J; Pinedo H M; Scheper R J; Baas F; Broxterman H J
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(19):8822-6.
1994: Flens M J; Izquierdo M A; Scheffer G L; Fritz J M; Meijer C J; Scheper R J; Zaman G J
Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
Cancer research 1994;54(17):4557-63.
1994: Van Wilsem E J; Van Hoogstraten I M; Brevé J; Scheper R J; Kraal G
Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair.
Immunology 1994;83(1):128-32.
1994: Palmer P A; Scharenberg J G; von Blomberg B M; Stam A G; Meijer C J; Roest G J; Franks C R; Scheper R J
Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.
Cancer immunology, immunotherapy : CII 1994;39(1):34-40.
1994: de Gruijl T D; Moore J J; de Vries E; von Blomberg-van der Flier B M; Fonk J C; Scheper R J
Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers.
Clinical and experimental immunology 1994;96(3):535-40.
1994: Mulder W M; Koenen H; van de Muysenberg A J; Bloemena E; Wagstaff J; Scheper R J
Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment.
Cancer immunology, immunotherapy : CII 1994;38(4):253-8.
1994: Jaspars E H; Bloemena E; Bonnet P; Scheper R J; Kaiserling E; Meijer C J
A new monoclonal antibody (3A5) that recognises a fixative resistant epitope on tissue macrophages and monocytes.
Journal of clinical pathology 1994;47(3):248-52.
1994: van Hoogstraten I M; von Blomberg B M; Boden D; Kraal G; Scheper R J
Non-sensitizing epicutaneous skin tests prevent subsequent induction of immune tolerance.
The Journal of investigative dermatology 1994;102(1):80-3.
1994: Scharenberg J G; Stam A G; von Blomberg B M; Roest G J; Palmer P A; Franks C R; Meijer C J; Scheper R J
The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1804-9.
1993: van Dinther-Janssen A C; Pals S T; Scheper R J; Meijer C J
Role of the CS1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium.
Annals of the rheumatic diseases 1993;52(9):672-6.
1993: Van Hoogstraten I M; Boos C; Boden D; Von Blomberg M E; Scheper R J; Kraal G
Oral induction of tolerance to nickel sensitization in mice.
The Journal of investigative dermatology 1993;101(1):26-31.
1993: Jaspars L H; van der Linden H C; Scheffer G L; Scheper R J; Meijer C J
Monoclonal antibody 4C7 recognizes an endothelial basement membrane component that is selectively expressed in capillaries of lymphoid follicles.
The Journal of pathology 1993;170(2):121-8.
1993: Scheper R J; Broxterman H J; Scheffer G L; Kaaijk P; Dalton W S; van Heijningen T H; van Kalken C K; Slovak M L; de Vries E G; van der Valk P
Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.
Cancer research 1993;53(7):1475-9.
1993: Bloemena E; Gall H; Ransom J H; Pomato N; Murray J H; Bos E; Scheper R J; Meijer C J; Hanna M G; Vermorken J B
Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine.
Cancer research 1993;53(3):456-9.
1992: van Hoogstraten I M; Boden D; von Blomberg M E; Kraal G; Scheper R J
Persistent immune tolerance to nickel and chromium by oral administration prior to cutaneous sensitization.
The Journal of investigative dermatology 1992;99(5):608-16.
1992: van Kalken C K; Giaccone G; van der Valk P; Kuiper C M; Hadisaputro M M; Bosma S A; Scheper R J; Meijer C J; Pinedo H M
Multidrug resistance gene (P-glycoprotein) expression in the human fetus.
The American journal of pathology 1992;141(5):1063-72.
1992: Oostendorp R A; Knol E F; Verhoeven A J; Scheper R J
An immunosuppressive retrovirus-derived hexapeptide interferes with intracellular signaling in monocytes and granulocytes through N-formylpeptide receptors.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(3):1010-5.
1992: Oostendorp R A; Schaaper W M; Post J; Von Blomberg B M; Meloen R H; Scheper R J
Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide.
European journal of immunology 1992;22(6):1505-11.
1992: Claessen A M; Bloemena E; Bril H; Meijer C J; Scheper R J
Locoregional administration of etoposide, but not of interleukin 2, facilitates active specific immunization in guinea pigs with advanced carcinoma.
Cancer research 1992;52(9):2440-6.
1992: Smit E F; de Vries E G; Timmer-Bosscha H; de Leij L F; Oosterhuis J W; Scheper R J; Weening J J; Postmus P E; Mulder N H
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.
International journal of cancer. Journal international du cancer 1992;51(1):72-8.
1992: Oostendorp R A; Schaaper W M; Post J; Meloen R H; Scheper R J
Synthetic hexapeptides derived from the transmembrane envelope proteins of retroviruses suppress N-formylpeptide-induced monocyte polarization.
Journal of leukocyte biology 1992;51(3):282-8.
1992: Quak J J; Schrijvers H G; Brakkee J G; Davis H D; Scheper R J; Meijer C J; Snow G B; Van Dongen G A
Expression and characterization of two differentiation antigens in human stratified squamous epithelia and carcinomas.
International journal of cancer. Journal international du cancer 1992;50(4):507-13.
1992: Baars J W; Fonk J C; Scheper R J; von Blomberg-van der Flier B M; Bril H; von Valk P; Pinedo H M; Wagstaff J
Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: a pilot study.
Biotherapy (Dordrecht, Netherlands) 1992;4(4):289-97.
1992: van Hoogstraten I M; de Groot J; Boden D; von Blomberg B M; Kraal G; Scheper R J
Development of a concomitant nickel and chromium sensitization model in the guinea pig.
International archives of allergy and immunology 1992;97(4):258-66.
1991: van Dinther-Janssen A C; Horst E; Koopman G; Newmann W; Scheper R J; Meijer C J; Pals S T
The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(12):4207-10.
1991: Schuurhuis G J; Broxterman H J; de Lange J H; Pinedo H M; van Heijningen T H; Kuiper C M; Scheffer G L; Scheper R J; van Kalken C K; Baak J P
Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
British journal of cancer 1991;64(5):857-61.
1991: Baars J W; Wagstaff J; Boven E; Vermorken J B; van Groeningen C J; Scheper R J; Fonk J C; Nijman H W; Franks C R; Damsma O
Phase I study on the sequential administration of recombinant human interferon-gamma and recombinant human interleukin-2 in patients with metastatic solid tumors.
Journal of the National Cancer Institute 1991;83(19):1408-10.
1991: Limpens J; Van Meijer M; Van Santen H M; Germeraad W T; Hoeben-Schornagel K; Breel M; Scheper R J; Kraal G
Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative.
Immunology 1991;73(3):255-63.
1991: Limpens J; Scheper R J
Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.
Clinical and experimental immunology 1991;84(3):383-8.
1991: Heimans J J; Wagstaff J; Schreuder W O; Wolbers J G; Baars J W; Polman C H; Scharenberg J G; Scheper R J; Palmer P A; Franks C R
Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2.
Surgical neurology 1991;35(3):244-7.
1991: Claessen A M; Valster H; Bril H; Steerenberg P A; Tan B T; Scheper R J
Tumor regression and induction of anti-tumor immunity by local chemotherapy of guinea-pigs bearing a line-10 hepatocarcinoma.
International journal of cancer. Journal international du cancer 1991;47(4):626-32.
1991: van Kalken C K; van der Valk P; Hadisaputro M M; Pieters R; Broxterman H J; Kuiper C M; Scheffer G L; Veerman A J; Meyer C J; Scheper R J
Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidney.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(1):55-62.
1991: van Hoogstraten I M; von Blomberg B M; Boden D; Kraal G; Scheper R J
Effects of oral exposure to nickel or chromium on cutaneous sensitization.
Current problems in dermatology 1991;20():237-41.
1991: Vreeburg K J; de Groot K; van Hoogstraten I M; von Blomberg B M; Scheper R J
Successful induction of allergic contact dermatitis to mercury and chromium in mice.
International archives of allergy and applied immunology 1991;96(2):179-83.
1990: Vreeburg K J; Van Hoogstraten I M; Von Blomberg B M; de Groot K; Scheper R J
Oral induction of immunological tolerance to chromium in the guinea pig.
Journal of dental research 1990;69(10):1634-9.
1990: Scheper R J; von Blomberg B M; de Groot J; Goeptar A R; Lang M; Oostendorp R A; Bruynzeel D P; van Tol R G
Low allergenicity of clonidine impedes studies of sensitization mechanisms in guinea pig models.
Contact dermatitis 1990;23(2):81-9.
1990: Bruynzeel I; Van der Raaij L M; Boorsma D M; De Haan P; Scheper R J; Kraal G; Willemze R
Spectophotometric quantification of cell-cell adherence by an enzyme-linked immuno-cell adhesion assay.
Journal of immunological methods 1990;132(1):51-6.
1990: Quak J J; van Dongen G; Koken M A; Brakkee J G; Scheper R J; Balm A J; de Jong L; Snow G B; Meijer C J
Identification of a 43-kDa nuclear antigen associated with proliferation by monoclonal antibody K 112.
International journal of cancer. Journal international du cancer 1990;46(1):50-5.
1990: Quak J J; Balm F J; Brakkee J G; Scheper R J; Meijer C J; Snow G B
Production of monoclonal antibodies to squamous cell carcinoma antigens.
Archives of otolaryngology--head & neck surgery 1990;116(2):181-5.
1990: van Dinther-Janssen A C; Pals S T; Scheper R; Breedveld F; Meijer C J
Dendritic cells and high endothelial venules in the rheumatoid synovial membrane.
The Journal of rheumatology 1990;17(1):11-7.
1990: Quak J J; Balm A J; van Dongen G A; Brakkee J G; Scheper R J; Snow G B; Meijer C J
A 22-kd surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified squamous and transitional epithelia.
The American journal of pathology 1990;136(1):191-7.
1990: Limpens J; Garssen J; Scheper R J
Local administration of cytostatic drugs enhances delayed-type hypersensitivity to Sendai virus in mice.
Clinical immunology and immunopathology 1990;54(1):161-5.
1990: Limpens J; Garssen J; Germeraad W T; Scheper R J
Enhancing effects of locally administered cytostatic drugs on T effector cell functions in mice.
International journal of immunopharmacology 1990;12(1):77-88.
1989: Quak J J; Balm A J; Brakkee J G; Scheper R J; Haisma H J; Braakhuis B J; Meijer C J; Snow G B
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice.
International journal of cancer. Journal international du cancer 1989;44(3):534-8.
1989: Pals S T; Horst E; Scheper R J; Meijer C J
Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease.
Immunological reviews 1989;108():111-33.
1989: Pals S T; Horst E; Ossekoppele G J; Figdor C G; Scheper R J; Meijer C J
Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma.
Blood 1989;73(4):885-8.
1989: Broxterman H J; Pinedo H M; Kuiper C M; van der Hoeven J J; de Lange P; Quak J J; Scheper R J; Keizer H G; Schuurhuis G J; Lankelma J
Immunohistochemical detection of P-glycoprotein in human tumor cells with a low degree of drug resistance.
International journal of cancer. Journal international du cancer 1989;43(2):340-3.
1989: Claessen A M; Valster H; Bril H; Meyer S; Scheper R J
Cell-mediated immunity is enhanced by cytostatic drugs continuously released at the site of antigenic stimulation.
Cancer immunology, immunotherapy : CII 1989;28(2):131-5.
1988: Kraal G; Shiamatey-Koolma R; Hoffer M; Baker D; Scheper R
Histochemical identification of guinea-pig macrophages by monoclonal antibody MR-1.
Immunology 1988;65(4):523-8.
1988: Scheper R J; Bulte J W; Brakkee J G; Quak J J; van der Schoot E; Balm A J; Meijer C J; Broxterman H J; Kuiper C M; Lankelma J
Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.
International journal of cancer. Journal international du cancer 1988;42(3):389-94.
1988: Pals S T; den Otter A; Miedema F; Kabel P; Keizer G D; Scheper R J; Meijer C J
Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(6):1851-3.
1988: Boerrigter G H; Bril H; Scheper R J
Hapten-specific antibodies in allergic contact dermatitis in the guinea pig.
International archives of allergy and applied immunology 1988;85(4):385-91.
1988: Goeptar A R; de Groot J; Lang M; van Tol R G; Scheper R J
Suppressive effects of transdermal clonidine administration on contact hypersensitivity reactions in guinea pigs.
International journal of immunopharmacology 1988;10(3):277-82.
1988: Pals S T; den Otter A; Miedema F; Kabel P; Keizer G D; Scheper R J; Meijer C J
MEL-14 and LFA-1, organ specific and non-specific adhesion molecules involved in homing of human lymphocytes.
Advances in experimental medicine and biology 1988;237():505-9.
1986: van der Burg C K; Bruynzeel D P; Vreeburg K J; von Blomberg B M; Scheper R J
Hand eczema in hairdressers and nurses: a prospective study. I. Evaluation of atopy and nickel hypersensitivity at the start of apprenticeship.
Contact dermatitis 1986;14(5):275-9.
1986: Tan B T; Limpens J; Koken M; Valster H; Scheper R J
Local administration of various cytostatic drugs after subcutaneous immunization enhances delayed-type hypersensitivity reaction to sheep red blood cells in mice.
Scandinavian journal of immunology 1986;23(5):605-9.
1980: Scheper R J; van Maarsseveen T C; van Dinther-Janssen A C
Comparative migration of guinea pig T and B lymphocytes from capillary tubes.
Cellular immunology 1980;53(1):19-28.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Rik Scheper

Research Profile (preview)

Physiology

Anatomy

Chemicals & Drugs

Living Beings

Procedures

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Rik Scheper (preview)

All Publications